Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Our lab data proves you can find top-performing cordless vacuums with long-lasting batteries and strong suction without breaking the bank.

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.